In 2023, the total value of assets held by Samsung Biologics amounted to around 16.1 trillion South Korean won. Samsung Biologics is a pharmaceutical company of Samsung Group and produces biopharmaceuticals for global companies. Biotech and health sector are among the key growth engine industries of Samsung Group.
Total assets of Samsung Biologics from 2015 to 2023 (in trillion South Korean won)
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Pharma and biotech M&A activity
Industry overview
5
- Premium Statistic Pharmaceutical market: worldwide revenue 2001-2023
- Premium Statistic Global biotech drug sales estimate 2012-2023
- Premium Statistic Top 10 biotech and pharmaceutical companies based on market cap 2024
- Premium Statistic Top 50 pharmaceutical companies - Rx sales and R&D spending 2022
- Premium Statistic Top pharmaceutical companies by capex growth in 2022
Number of deals
7
- Premium Statistic Planned and actual healthcare and life sciences activity in 2020, by subsector
- Basic Statistic Global number of life sciences sector deals 2013-2021
- Premium Statistic Number of biopharmaceutical deals worldwide 2016-2020, by type
- Basic Statistic Number of cell and gene therapy deals worldwide 2016-2020, by type
- Premium Statistic Number of biopharma M&A deals worldwide 2010-2019, by companies
- Basic Statistic Number of biopharma M&A deals worldwide 2010-2019, by total transaction value
- Premium Statistic Number of biopharma M&A deals worldwide 2010-2019, by industry
Value of deals
5
- Premium Statistic Largest M&A pharmaceutical deals ever as of 2024
- Basic Statistic Global value of life sciences sector deals 2013-2021
- Basic Statistic Top completed life sciences deals based on value globally 2020
- Premium Statistic Value of biopharma M&A deals worldwide 2010-2019, by industry
- Premium Statistic Average value of biopharma M&A deals worldwide 2010-2019, by industry
Mega-merger: BMS/Celgene
5
- Premium Statistic Bristol-Myers Squibb's revenue 2006-2023
- Basic Statistic Bristol-Myers Squibb revenue by segment 2015-2020
- Basic Statistic Celgene's revenue and net income 2006-2018
- Premium Statistic Revenue of Celgene 2016-2018, by therapeutic area
- Premium Statistic Top pharma companies worldwide 2024, by size of R&D pipeline
2021 outlook
4
- Basic Statistic Expected acquisitions of biopharma companies by type of asset 2021
- Basic Statistic Expected investment in biopharma and diagnostic lab services 2021, by type
- Basic Statistic Expected valuation changes in healthcare and life sciences 2021, by subsector
- Premium Statistic Expected investment changes in biopharma and diagnostic lab services 2021
Further Content: You might find this interesting as well
DART. (March 7, 2024). Total assets of Samsung Biologics from 2015 to 2023 (in trillion South Korean won) [Graph]. In Statista. Retrieved May 18, 2024, from https://www.statista.com/statistics/1393948/samsung-biologics-total-assets/
DART. "Total assets of Samsung Biologics from 2015 to 2023 (in trillion South Korean won)." Chart. March 7, 2024. Statista. Accessed May 18, 2024. https://www.statista.com/statistics/1393948/samsung-biologics-total-assets/
DART. (2024). Total assets of Samsung Biologics from 2015 to 2023 (in trillion South Korean won). Statista. Statista Inc.. Accessed: May 18, 2024. https://www.statista.com/statistics/1393948/samsung-biologics-total-assets/
DART. "Total Assets of Samsung Biologics from 2015 to 2023 (in Trillion South Korean Won)." Statista, Statista Inc., 7 Mar 2024, https://www.statista.com/statistics/1393948/samsung-biologics-total-assets/
DART, Total assets of Samsung Biologics from 2015 to 2023 (in trillion South Korean won) Statista, https://www.statista.com/statistics/1393948/samsung-biologics-total-assets/ (last visited May 18, 2024)
Total assets of Samsung Biologics from 2015 to 2023 (in trillion South Korean won) [Graph], DART, March 7, 2024. [Online]. Available: https://www.statista.com/statistics/1393948/samsung-biologics-total-assets/